Glossary · Treatments

Oxybutynin

Also called: Ditropan.

Definition: Oxybutynin is an anticholinergic medication FDA-approved for overactive bladder. It has also been studied for vasomotor symptoms and shows modest hot flash reduction (~25–35%). Cognitive side effects from anticholinergic burden limit long-term use in older women.

Detailed definition

Oxybutynin is a competitive muscarinic acetylcholine receptor antagonist FDA-approved for overactive bladder symptoms (urgency, frequency, urge incontinence). Off-label use for vasomotor symptoms is supported by several RCTs showing reductions of roughly 25–35% in hot flash frequency at doses of 2.5–7.5 mg daily. The trade-off is anticholinergic burden — dry mouth, constipation, blurred vision, urinary retention, and (most concerning in older women) cognitive impairment. Long-term anticholinergic exposure has been associated with increased dementia risk in observational studies, so oxybutynin is generally a short-to-medium term option rather than a long-term solution.

Why it matters in menopause

Oxybutynin can be useful for women with both overactive bladder and vasomotor symptoms, treating both with one medication. For long-term hot flash management, options with cleaner cognitive profiles (fezolinetant, venlafaxine) are typically preferred.

Sources

External references: Wikipedia.

← Back to full glossary